Retraction: Pyrroloquinoline Quinine Inhibits RANKL-Mediated Expression of NFATc1 in Part via Suppression of c-Fos in Mouse Bone Marrow Cells and Inhibits Wear Particle-Induced Osteolysis in Mice. [PDF]
PLOS One Editors.
europepmc +1 more source
[Corrigendum] Dihydroartemisinin attenuates osteoclast formation and bone resorption via inhibiting the NF‑κB, MAPK and NFATc1 signaling pathways and alleviates osteoarthritis. [PDF]
Ding D +5 more
europepmc +1 more source
Microbial-Derived Daidzin (Eco-3) Suppresses RANKL-Induced Osteoclastogenesis by Targeting the TBK1-NFATc1 Signaling Axis. [PDF]
Perumal NL, Koo KB, Park GY, Jang BC.
europepmc +1 more source
Non-redundant functions of NFATc1 in survival and NFATc2 in generation of exhausted CD8<sup>+</sup> T cells. [PDF]
Sampere-Birlanga S +9 more
europepmc +1 more source
Neddylation of NFATc1 and Runx2 regulates osteoclast-osteoblast balance and represents a dual-action therapeutic target for postmenopausal osteoporosis. [PDF]
Lee J +8 more
europepmc +1 more source
Oxidative Stress and Metabolic Reprogramming in Osteoclastogenesis: Molecular Mechanisms and Antioxidant Therapy for Bone Disorders. [PDF]
Alam MI +7 more
europepmc +1 more source
Bushen Huoxue decoction attenuates osteoporosis in ovariectomized rats through suppressing osteoclast differentiation by targeting sirtuin 1 to deactivate nuclear factor-κB. [PDF]
Shuai C +7 more
europepmc +1 more source
Asarinin Inhibits RANKL-Induced Osteoclast Differentiation by Targeting the p38/ERK-c-Fos-NFATc1 Axis. [PDF]
Zhang L +8 more
europepmc +1 more source
[<i>Liuwei Dihuang</i> Pill regulate osteoclast membrane fusion to improve postmenopausal osteoporosis in mice: the CLCF1/NFATc1 signaling axis as a therapeutic target]. [PDF]
Zheng R, Xie L, Huang X, Ge J.
europepmc +1 more source
Non-Coding Structural Variants in Regulatory Regions and High Polygenic Burden May Jointly Contribute to Early-Onset Familial Hashimoto's Thyroiditis. [PDF]
Boraska Perica V +11 more
europepmc +1 more source

